NCT07345247 RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
| NCT ID | NCT07345247 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara University |
| Condition | Liver Cancer, Adult |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-08-01 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Radiation segmentectomy (RS) refers to selective infusion of Y-90 microspheres to the tumor bearing hepatic segment of hepatic artery. Majority of the data on RS is based on the Glass microspheres experience. Due to different properties of Resin and Glass microspheres description of dose limits to the segment for effectiveness of treatments with Resin microspheres are needed. Based on this background in this study it is aimed to evaluate the safety and efficacy of RS with resin microspheres in HCC patients. Secondly, it is planned to describe the dose limits for complete radiological response.
Eligibility Criteria
Inclusion Criteria: * Patients aged ≥18 years * Underwent RE as a RS intent (have single or \<3 tumors in same or neighboring 2 segments) for the treatment of HCC or metastatic tumor to liver. * Presence of extrahepatic disease * Tumor size less than 8 cm * Child Pugh Score \<B9 Exclusion Criteria: * Presence of macrovascular invasion, * Presence of extrahepatic disease, * Cholangiocarcinoma or mixed HCC-cholangiocarcinoma * Not willing to attend follow-up visits.
Frequently Asked Questions
Who can join the NCT07345247 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Cancer, Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07345247 currently recruiting?
Yes, NCT07345247 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ankara University to inquire about joining.
Where is the NCT07345247 trial being conducted?
This trial is being conducted at Adana, Turkey (Türkiye), Adana, Turkey (Türkiye), Adana, Turkey (Türkiye), Ankara, Turkey (Türkiye) and 11 additional locations.
Who is sponsoring the NCT07345247 clinical trial?
NCT07345247 is sponsored by Ankara University. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.